Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where a protected aminomethyl morpholine moiety is required. The tert-butyloxycarbonyl (Boc) group serves as a protecting group for the amine, allowing selective reactivity during multi-step syntheses. The morpholine ring contributes to solubility and bioavailability in drug molecules, making this compound valuable in medicinal chemistry for optimizing pharmacokinetic properties. Commonly employed in the preparation of kinase inhibitors, CNS agents, and other bioactive molecules where structural complexity and polarity are important.